SCHEMBL25473279

SCHEMBL25473279

c1ccc(-c2ccc3oc4c(-c5cccc(-c6cccc7c6oc6ccccc67)c5)ncnc4c3c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ PIM1 P11309 1/20 0.41
▸ CSNK2A2 P19784 1/20 0.41
▸ CSNK2B P67870 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ PIM2 Q9P1W9 1/20 0.41
▸ LIMK1 P53667 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ GGPS1 O95749 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23627799 1.00 ALOX5 (0.49) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473288 1.00 ALOX5 (0.49) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473233 1.00 ALOX5 (0.49) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473207 1.00 ALOX5 (0.49) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473270 1.00 ALOX5 (0.49) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473188 1.00 ALOX5 (0.49) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473284 0.99 ALOX5 (0.48) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473205 0.98 ALOX5 (0.46) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473247 0.98 ALOX5 (0.51) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B
SCHEMBL25473227 0.98 ALOX5 (0.51) ALOX5SMN1; SMN2PIM1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147615-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147615-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE CRY1, H1-0, OLA1 ALOX5 1738/4885SMN1; SMN2 2949/4885PIM1 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback